Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evolent Health

9.47
-0.1300-1.35%
Post-market: 9.470.00000.00%16:36 EDT
Volume:2.09M
Turnover:19.76M
Market Cap:1.09B
PE:-11.62
High:9.61
Open:9.33
Low:9.29
Close:9.60
Loading ...

Evolent Health: Buy Rating Affirmed Amid Cost Management and Revenue Growth Strategies

TIPRANKS
·
08 Nov 2024

Evolent Health Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
08 Nov 2024

Stock Track | Evolent Health Shares Plummet 36% After Disastrous Q3 Earnings and Guidance Cut

Stock Track
·
08 Nov 2024

Evolent stock tumbles 34% post-market on Q3 report, lowered guidance

seekingalpha
·
08 Nov 2024

Evolent Health (EVH) Q3 Earnings and Revenues Lag Estimates

Zacks
·
08 Nov 2024

CORRECTION: Evolent Health Q3 Adj $0.04 Misses $0.34 Estimate, Sales $621.40M Miss $627.15M Estimate

Benzinga
·
08 Nov 2024

Stock Track | Evolent Health Stock Plunges 32% After Q3 Earnings Miss and Guidance Cut

Stock Track
·
08 Nov 2024

Evolent Health Q3 2024 Adj. EPS $(0.27) Misses $0.34 Estimate, Sales $621.400M Miss $627.151M Estimate

Benzinga
·
08 Nov 2024

Humana and Evolent Expand Partnership to Enhance Oncology Care

THOMSON REUTERS
·
08 Nov 2024

Humana and Evolent Expand Partnership to Enhance Oncology Care

Business Wire
·
08 Nov 2024

BRIEF-Evolent Health Q3 Revenue USD 621.401 Million Vs. IBES Estimate USD 627.2 Million

Reuters
·
08 Nov 2024

Evolent Health- for Year Ending Dec 31, Revenue Is Expected to Be in Range of About $2.55 Bln to $2.575 Bln

THOMSON REUTERS
·
08 Nov 2024

Evolent Health Q3 Adjusted Ebitda Margin 5.1%

THOMSON REUTERS
·
08 Nov 2024

Evolent Health Q3 Adjusted Ebitda USD 31.801 Million VS. Ibes Estimate USD 62.7 Million

THOMSON REUTERS
·
08 Nov 2024

Evolent Announces Third Quarter 2024 Results

PR Newswire
·
08 Nov 2024

AstraZeneca showcases strength of hematology portfolio and pipeline at ASH 2024

Business Wire
·
07 Nov 2024